Analyzing tissue-agnostic therapies for the treatment of primary brain tumors

Researchers from Miami Cancer Institute, part of Baptist Health South Florida, have published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The article describes the current and potential impact of tissue-agnostic therapies on the management of PBTs.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart